The COVID-19 pandemic in children and young people during 2020-2021 : learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment
Abstract
The initial research questions posed by the scientists faced with SARS-CoV-2 outbreaks were focused on documenting the clinical presentation and the characteristics of the spread of the SARS-CoV-2 virus among CYP [1-3], and the optimal ways to diagnose CYP and treat those in need [1,4]. It quickly became apparent that younger age groups have a considerably milder clinical presentation, but also that they can very rarely develop a considerably more serious Multisystem Inflammatory Syndrome in Children (MISC) [1]. A special interest arose in how best to protect those particularly vulnerable. In this Editorial, we discuss the development of scientific evidence related to those research questions in children and young people during the first two years of the COVID-19 pandemic, based on the information available until December 1st, 2021
Citation
Rudan , I , Adeloye , D , Katikireddi , S V , Murray , J , Simpson , C , Shah , S A , Robertson , C , Sheikh , A & EAVE II collaboration 2021 , ' The COVID-19 pandemic in children and young people during 2020-2021 : learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment ' , Journal of Global Health , vol. 11 , 01010 . https://doi.org/10.7189/JOGH.11.01010
Publication
Journal of Global Health
Status
Peer reviewed
ISSN
2047-2978Type
Journal item
Rights
Copyright © 2021 The Author(s); JOGH © 2021 ISGH. This work is licensed under a Creative Commons Attribution 4.0 International License.
Description
Funding: EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and Scottish Government DG Health and Social Care.). SVK acknowledges funding from a NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2) and the Scottish Government Chief Scientist Office (SPHSU17).Collections
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Related items
Showing items related by title, author, creator and subject.
-
Effect of free medicine distribution on health care costs in Canada over 3 years : a secondary analysis of the CLEAN meds randomized clinical trial
Persaud, Nav; Bedard, Michael; Boozary, Andrew; Glazier, Richard H; Gomes, Tara; Hwang, Stephen W; Jüni, Peter; Law, Michael R; Mamdani, Muhammad; Manns, Braden; Martin, Danielle; Morgan, Steven G; Oh, Paul; Pinto, Andrew D; Shah, Baiju R; Sullivan, Frank; Umali, Norman; Thorpe, Kevin E; Tu, Karen; Wu, Fangyun; Laupacis, Andreas; CLEAN Meds study team (2023-05-26) - Journal articleIMPORTANCE : Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE : To determine the effect of eliminating out-of-pocket medication ... -
Association between tobacco control policies and current smoking across different occupational groups in the EU between 2009 and 2017
So, Vivian H. T.; Best, Catherine; Currie, Dorothy; Haw, Sally (2019-08) - Journal articleBACKGROUND: This study investigated the cross-national and longitudinal associations between national tobacco control policies and current smoking in 28 European Union (EU) member states between 2009 and 2017. It also ... -
Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy : study protocol of a cluster randomized clinical trial (Multi-PAP project)
Prados-Torres, Alexandra; del Cura-González, Isabel; Prados-Torres, Daniel; López-Rodríguez, Juan A.; Leiva-Fernández, Francisca; Calderón-Larrañaga, Amaia; López-Verde, Fernando; Gimeno-Feliu, Luis A.; Escortell-Mayor, Esperanza; Pico-Soler, Victoria; Sanz-Cuesta, Teresa; Bujalance-Zafra, M. Josefa; Morey-Montalvo, Mariel; Boxó-Cifuentes, José Ramón; Poblador-Plou, Beatriz; Fernández-Arquero, José Manuel; González-Rubio, Francisca; Ramiro-González, María D.; Coscollar-Santaliestra, Carlos; Martín-Fernández, Jesús; Barnestein-Fonseca, M. Pilar; Valderas-Martínez, José María; Marengoni, Alessandra; Muth, Christiane; Multi-PAP Group; Hernández-Santiago, Virginia; Azcoaga-Lorenzo, Amaya (2017-04-27) - Journal articleBackground: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of ...